Gewurz Benjamin E

30PUBLICATIONS

99CO-AUTHORS

Haematological tumoursPredictive and prognostic markersMolecular targetsEpidemiological methodsMedical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jun 15, 2026

Arginine metabolism supports <i>de novo</i> pyrimidine biosynthesis to block DNA damage and maintain Epstein-Barr virus latency.

|May 14, 2026

EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers.

|Apr 10, 2026

CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

Eric M Burton, Yifei Liao, Davide Maestri

|Feb 10, 2026

Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.

Sarah Preston-Alp, Yin Wang, Matteo Bergonzoni

|Jan 26, 2026

Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.

Yizhe Sun, Shunji Li, Bidisha Mitra

|Nov 28, 2025

The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane.

Yin Wang, Yifei Liao, Yizhe Sun

Pageof 5

Frequent Collaborators

Mingxiang Teng

Bo Zhao

Rui Guo

Italo Tempera

Yifei Liao

Paul M Lieberman

Yohei Narita

Yin Wang

Ethel Cesarman

Hardik Shah

Frequent Collaborators

Mingxiang Teng

Bo Zhao

Rui Guo

Italo Tempera